Impact of COVID-19 pandemic on uveitis patients receiving immunomodulatory and biological therapies (COPE STUDY) | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Clinical science

Impact of COVID-19 pandemic on uveitis patients receiving immunomodulatory and biological therapies (COPE STUDY)

Free

Online download statistics by month:

Online download statistics by month: October 2020 to April 2022

	Abstract	Full	Pdf
Oct 2020	2174	2145	1471
Nov 2020	1215	1203	761
Dec 2020	470	448	39
Jan 2021	616	616	51
Feb 2021	372	372	26
Mar 2021	337	337	31
Apr 2021	249	250	24
May 2021	283	286	18
Jun 2021	164	166	21
Jul 2021	146	146	12
Aug 2021	154	155	24
Sep 2021	134	134	23
Oct 2021	184	186	13
Nov 2021	116	116	25
Dec 2021	404	405	24
Jan 2022	408	400	59
Feb 2022	184	184	30
Mar 2022	130	129	33
Apr 2022	130	126	32
Total	7870	7804	2717